The Second Judicial District Court (SJDC) is pleased to announce a new partnership with Averhealth, a nationally recognized leader in substance use monitoring. Effective November 3, 2025, drug and alcohol testing services within SJDC’s Pretrial Services and Specialty Court Programs will be conducted through Averhealth.
Averhealth has more than 30 years of experience providing comprehensive, evidence-based drug and alcohol testing, offering greater reliability, accountability, and improved outcomes for justice-involved individuals. The company’s laboratory is one of only 30 in the United States accredited by the College of American Pathologists – Forensic Drug Testing (CAP-FDT) and also holds accreditation from the U.S. Department of Health and Human Services Clinical Laboratory Improvements Amendment (CLIA) and the Drug Enforcement Administration (DEA).
This transition is part of SJDC’s ongoing commitment to public safety, rehabilitation, and high-quality service delivery. By leveraging Averhealth’s advanced technology and consistent testing protocols, the Court aims to provide timely and accurate monitoring for participants in our justice programs.
New Drug Testing Collection Location and Hours:
Averhealth – Reno Facility
1155 W. 4th St., Suite 101
Reno, NV 89503
Weekdays: 6 a.m. – 7 p.m. (Closed from 2-3 p.m.)
Weekends & Holidays: 7 a.m. – 7 p.m. (Closed from 2-3 p.m.)
Participants currently enrolled in SJDC’s Pretrial Services or Specialty Court Programs have received direct notification and instructions regarding the transition.
Questions and media inquiries:
Brooke Howard
Specialty Court Programs Manager
Second Judicial District Court
Brooke.Howard@washoecourts.us
775-328-3839